D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
US9060962B2 · kind B2 · utility
0Cited by
25References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | May 3, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions including D-tagatose along with a stilbene or stilbenoid component, or a salt or derivative thereof. Methods of prophylaxis and therapy by administering to a mammal a pharmaceutically effective amount of D-tagatose, optionally in combination with a stilbene or stilbenoid component, or a salt or derivative thereof to prevent or treat atherosclerosis, the metabolic syndrome, obesity, or diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.